Antiplatelet prophylaxis. Combination treatment may cause bleeding.

Antiplatelet prophylaxis. Combination treatment may cause bleeding.

Bibliographic Details
Main Authors:	Seagroatt, V, Bulstrode, C, Murray, D
Format:	Journal article
Language:	English
Published:	1994

Similar Items

ANTIPLATELET PROPHYLAXIS - COMBINATION TREATMENT MAY CAUSE BLEEDING - THE SAME FOR MEN AND WOMEN - REPLY
by: Collins, R, et al.
Published: (1994)

ANTIPLATELET PROPHYLAXIS - COMBINATION TREATMENT MAY CAUSE BLEEDING - THE SAME FOR MEN AND WOMEN - REPLY
Published: (1994)

Antiplatelet Therapy and Bleeding Outcomes With CYP2C19 Genotyping
by: James C. Coons PharmD, et al.
Published: (2022-12-01)

Bleeding risk of cerebral cavernous malformations in patients on statin and antiplatelet medication
by: L. Marques, et al.
Published: (2022-01-01)

SURGICAL TREATMENT OF HEMORRHOIDAL BLEEDING IN PATIENTS WITH CARDIOVASCULAR DISEASES UNDER ANTICOAGULANT AND ANTIPLATELET THERAPY
by: A. Z. Tsitskarava, et al.
Published: (2019-12-01)

THE METHOD OF SURGICAL TREATMENT AND PROPHYLAXIS OF BLEEDING FROM VARICEAL OF THE ESOPHAGUS AND STOMACH
by: A. . Shapovalov, et al.
Published: (2015-09-01)

Bleeding Risk with Dual Antiplatelet Therapy and Gastrostomy Tube Placement:
by: Manesh K. Gangwani
Published: (2023-05-01)

Refining prediction of major bleeding on antiplatelet treatment after transient ischaemic attack or ischaemic stroke
by: Hilkens, NA, et al.
Published: (2020)

Management of Bleeding Events Associated with Antiplatelet Therapy: Evidence, Uncertainties and Pitfalls
by: Anne Godier, et al.
Published: (2020-07-01)

Acute Coronary Syndrome, Antiplatelet Therapy, and Bleeding: A Clinical Perspective
by: Gregorio Tersalvi, et al.
Published: (2020-07-01)

Regulation of Key Antiplatelet Pathways by Bioactive Compounds with Minimal Bleeding Risk
by: Eduardo Fuentes, et al.
Published: (2021-11-01)

Bleeding with intensive versus guideline antiplatelet therapy in acute cerebral ischaemia
by: Lisa J. Woodhouse, et al.
Published: (2023-07-01)

Comparison of predictive value of risk scores for gastrointestinal bleeding in antiplatelet therapy
by: Mei-na Lv, et al.
Published: (2022-05-01)

Costs of bleeding on long-term antiplatelet treatment without routine co-prescription of proton-pump inhibitors
by: Luengo-Fernandez, R, et al.
Published: (2019)

Combination treatment for falciparum prophylaxis.
by: White, N
Published: (1987)

Bleeding tendency in dual antiplatelet therapy with aspirin/clopidogrel: rescue of the template bleeding time in a single-center prospective study
by: Altman Raul, et al.
Published: (2012-01-01)

Platelets to prevent progression of trauma-induced head bleed in patients on antiplatelet medication
by: Conor Holland, et al.
Published: (2023-06-01)

Long-term dual antiplatelet therapy and nuisance bleeding: impact on quality of life
by: Gennaro Ratti, et al.
Published: (2022-11-01)

Prophylaxis for stress ulcer bleeding in the intensive care unit
by: J.M. Avendaño-Reyes, et al.
Published: (2014-01-01)

The Combination of Stent and Antiplatelet Therapy May Be Responsible of Parenchymal Magnetic Susceptibility Artifacts after Endovascular Procedure
by: Fanny Bourhis-Guizien, et al.
Published: (2021-11-01)

Early time course of major bleeding on antiplatelet therapy after TIA or ischemic stroke
by: Hilkens, N, et al.
Published: (2018)

Effects of thienopyridine class antiplatelets on bleeding outcomes following robot-assisted radical prostatectomy
by: Masashi Kubota, et al.
Published: (2024-03-01)

Bleeding after tooth extraction and measures for its control in patients treated with antiplatelet agents
by: Carmen Blanca Ciria González, et al.
Published: (2022-12-01)

Antiplatelet treatment and gastro-intestinal hemorrhage risk
by: D. V. Duplyakov
Published: (2005-08-01)

Pooled Analysis of Bleeding, Major Adverse Cardiovascular Events, and All‐Cause Mortality in Clinical Trials of Time‐Constrained Dual‐Antiplatelet Therapy After Percutaneous Coronary Intervention
by: John D. McClure, et al.
Published: (2020-08-01)

Managing Anticoagulation and Dual Antiplatelet Therapy in Patients with Active Bleed or Upcoming Procedure: A Scoping Review
by: Julia L. Berkowitz, et al.
Published: (2023-06-01)

Recurrent Non-Variceal Upper Gastrointestinal Bleeding among Patients Receiving Dual Antiplatelet Therapy
by: Ah Young Yoo, et al.
Published: (2023-11-01)

No Differences in Gastrointestinal Bleeding Risk among Clopidogrel-, Ticagrelor-, or Prasugrel-Based Dual Antiplatelet Therapy
by: Viviana Laredo, et al.
Published: (2020-05-01)

Dual Antiplatelet Therapy and Cancer; Balancing between Ischemic and Bleeding Risk: A Narrative Review
by: Grigorios Tsigkas, et al.
Published: (2023-03-01)

Absence of bleeding upon dual antiplatelet therapy in a patient with a immune GPVI deficiency
by: Stéphane Loyau Inserm, et al.
Published: (2021-07-01)

PLATELET FUNCTION TEST FOR THE ASSESSMENT OF THROMBOSIS AND BLEEDING RISK IN CHD PATIENTS TAKING ANTIPLATELET MEDICATIONS
by: A. L. Komarov, et al.
Published: (2015-03-01)

Antiplatelet agents for the treatment and prevention of atherothrombosis.
by: Patrono, C, et al.
Published: (2011)

Bleeding and thrombosis outcomes in hospitalised COVID-19 patients on low-molecular-weight heparin and antiplatelet therapy
by: V Pillay-Fuentes Lorente, et al.
Published: (2022-07-01)

Intervertebral disk diseases : causes, diagnosis, treatment, and prophylaxis /
by: 1939-
Published: (c200)

Risk Scores of Bleeding Complications in Patients on Dual Antiplatelet Therapy: How to Optimize Identification of Patients at Risk of Bleeding after Percutaneous Coronary Intervention
by: Francesco Pelliccia, et al.
Published: (2022-06-01)

Performance of PRECISE-DAPT and Age–Bleeding–Organ Dysfunction Score for Predicting Bleeding Complication During Dual Antiplatelet Therapy in Chinese Elderly Patients
by: Liang Dong, et al.
Published: (2022-07-01)

All bleeding matters … but the details may not
by: Sarah H. O’Brien
Published: (2020-01-01)

Antiplatelet agents for the treatment and prevention of coronary atherothrombosis
by: Patrono, C, et al.
Published: (2017)

Bleeding and thrombotic events in bevacizumab-treated patients with colorectal cancer on novel oral anticoagulants and antiplatelet medications
by: Shinji Rho, et al.
Published: (2023-03-01)

Hemophilia prophylaxis adherence and bleeding using a tailored, frequency‐escalated approach: The Canadian Hemophilia Primary Prophylaxis Study
by: Saunya Dover, et al.
Published: (2020-02-01)